TY - JOUR
T1 - Exploring anal self-examination as a screening tool for women at risk for anal cancer
T2 - awareness, interest, and barriers to behavioral uptake
AU - Moskowitz, David A.
AU - Rahman, Musarrat
AU - Li, Dennis H.
N1 - Funding Information:
We would like to acknowledge the Division of Health Behavior and Community Health at the School of Health Sciences & Practice, New York Medical College, for its funding. We would also like to thank Atticus Ranck and Drs. Barbara Greenberg, Penny Liberatos, Ben Watson, and Jason Ong for their guidance and advice. Special recognition to Dr. Phillip Moskowitz for his medical expertise on this work and for retiring after 43 years of saving lives as a gastroenterologist.
Funding Information:
Funding This study was funded by the Department of Public Health at the School of Health Sciences & Practice, New York Medical College.
Publisher Copyright:
© 2019, Springer Nature Switzerland AG.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Purpose: Anal cancer is the second most common human-papillomavirus-related cancer in women, with women also at an elevated risk of incidence relative to men. Anal self-examination (ASE) is an efficient way for women to screen between provider visits for potential anal masses. While studied in male populations, no research has explored women’s awareness of the self-test. Methods: In response, 345 women recruited from online advertisements and listservs were surveyed to assess their experiences using health care, history of Pap smears, knowledge of anal cancer, awareness and attitudes surrounding ASEs, and potential educational modalities to promote ASE enactment. Results: Results indicated the sample failed two key anal cancer knowledge tests (receiving a 68%/100% for risk factors and 61%/100% for signs/symptoms), and only 2.3% of participants had ever heard of ASEs before the survey. Most thought ASEs would be somewhat helpful as a screening tool, but little interest was shown towards future performance. Analyses revealed this disinterest was due to lack of knowledge, perceived discomfort with performing ASEs, and perceived irrelevance of ASEs. Conclusions: Future interventions should push for a stronger role of providers (e.g., gynecologists) in anal health, education, and screening. Additionally, campaigns should be crafted to promote the ASE as an easy, at-home screening tool that could trigger an early warning for anal disease.
AB - Purpose: Anal cancer is the second most common human-papillomavirus-related cancer in women, with women also at an elevated risk of incidence relative to men. Anal self-examination (ASE) is an efficient way for women to screen between provider visits for potential anal masses. While studied in male populations, no research has explored women’s awareness of the self-test. Methods: In response, 345 women recruited from online advertisements and listservs were surveyed to assess their experiences using health care, history of Pap smears, knowledge of anal cancer, awareness and attitudes surrounding ASEs, and potential educational modalities to promote ASE enactment. Results: Results indicated the sample failed two key anal cancer knowledge tests (receiving a 68%/100% for risk factors and 61%/100% for signs/symptoms), and only 2.3% of participants had ever heard of ASEs before the survey. Most thought ASEs would be somewhat helpful as a screening tool, but little interest was shown towards future performance. Analyses revealed this disinterest was due to lack of knowledge, perceived discomfort with performing ASEs, and perceived irrelevance of ASEs. Conclusions: Future interventions should push for a stronger role of providers (e.g., gynecologists) in anal health, education, and screening. Additionally, campaigns should be crafted to promote the ASE as an easy, at-home screening tool that could trigger an early warning for anal disease.
KW - Anal cancer
KW - Anal self-examination
KW - Cancer screening
KW - HPV
KW - Women’s sexual health
UR - http://www.scopus.com/inward/record.url?scp=85065157563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065157563&partnerID=8YFLogxK
U2 - 10.1007/s10552-019-01175-1
DO - 10.1007/s10552-019-01175-1
M3 - Article
C2 - 31037559
AN - SCOPUS:85065157563
SN - 0957-5243
VL - 30
SP - 559
EP - 568
JO - Cancer Causes and Control
JF - Cancer Causes and Control
IS - 6
ER -